We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current BVAXF market cap is 12.22M. The company's latest EPS is CAD -0.0311 and P/E is -1.61.
Year End 31 October 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Operating Income | -11k | -733k | -4.17M | -9.36M | -7.9M |
Net Income | -230k | -1.17M | -6.46M | -11.73M | -7.69M |
Year End 31 October 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
Total Assets | 306k | 10.46M | 8.5M | 865k | 113k |
Total Liabilities | 116k | 900k | 327k | 1.64M | 3.49M |
Total Equity | 190k | 9.56M | 8.18M | -774k | -3.37M |
Year End 31 October 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
Operating | -231k | -1.23M | -5.29M | -1.57M | -1.06M |
Investing | N/A | 61k | N/A | N/A | N/A |
Financing | 444k | 3.35M | 3.44M | 1.11M | 917k |
Market Cap | 12.22M |
Price to Earnings Ratio | -1.61 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 0 |
Price to Book Ratio | -3.66 |
Dividend Yield | - |
Shares Outstanding | 246.93M |
Average Volume (1 week) | 498.32k |
Average Volume (1 Month) | 503.27k |
52 Week Change | 277.86% |
52 Week High | 0.0758 |
52 Week Low | 0.0091 |
Spread (Intraday) | 0.05 (83.31%) |
Company Name | Biovaxys Technology Corporation (QB) |
Address |
25th floor, 666 burrard street vancouver, british columbia V6C 2X8 |
Website | https://www.biovaxys.com |
Industry | miscellaneous metal ores,nec (1099) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions